AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
Diana Rafael(University of Lisbon), Mafalda Videira(University of Lisbon), Joaquin Seras‐Franzoso(Universitat Autònoma de Barcelona), Sara Montero‐Herradón(Universitat Autònoma de Barcelona), Joan Sayós(Beth Israel Deaconess Medical Center), Ibane Abasolo(Universitat Autònoma de Barcelona), Petra Gener(CIBBIM-Nanomedicine), Diego Arango(Universitat Autònoma de Barcelona), Fernanda Andrade(Universidade do Porto), Helena F. Florindo(University of Lisbon), Manuel Hidalgo(Spanish National Cancer Research Centre), Yolanda Fernández(CIBBIM-Nanomedicine), Simó Schwartz(CIBBIM-Nanomedicine)
Cited by 39
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
A DNA methylation fingerprint of 1628 human samples
|Genome Research|2011|418